Orchid Pharma Share Price
Small Cap | Pharmaceuticals and health care | NSE: ORCHPHARMA | BSE: 524372
₹920.15 
43.80 (5.00 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 876.10
High (₹) 920.15
Low (₹) 874.00
Prev. Close (₹) 876.35
Volume 10,360
VWAP (₹) 907.00
ROCE (%) 8.37
Industry P/E 43.99
TTM P/E 42.31
P/B Ratio 3.98
Market Cap (₹) Cr.4,657.28
Dividend Yield (%)--
EPS (₹) 19.06
ROE8.27%
Sales Growth (%) 23.05
Profit Growth (%)96.12
Day Range
920.15920.15
52 Week Range
799.751,998.00
Historical Returns
Returns (6M)
-33.22 %
Returns (1Y)
-24.4 %
Returns (3Y)
221.79 %
Returns (5Y)
5011.94 %
Returns (6M)
-33.22 %
Returns (1Y)
-24.4 %
Returns (3Y)
221.79 %
Returns (5Y)
5011.94 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (67.93%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Company with 67.93% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BEARISHRSI 27.88
MFI 20.09
ATR 85.92
Commodity Channel Index -97.05
ROC125 -33.47
ROC21 -36.91
Williams %R -83.09
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 935.54 | 950.92 | 981.69 | 904.77 | 889.39 | 858.62 | 843.24 |
| Week Ago | 1,023.25 | 1,101.05 | 1,139.95 | 984.35 | 906.55 | 867.65 | 789.85 |
| Month Ago | 1,632.24 | 1,720.32 | 1,771.29 | 1,581.27 | 1,493.19 | 1,442.22 | 1,354.14 |
EMA & SMA
920.15
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
18
5 Day 857.04
9 Day 1029.23
10 Day 1061.87
12 Day 1160.33
14 Day 1174.29
20 Day 1223.29
26 Day 1311.47
50 Day 1525.45
100 Day 1484.01
200 Day 1366.38
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| DHANUKA LABORATORIES LIMITED | bulk | Sell | 28 Nov, 2023 | ₹571.28 | 13,00,000 | BSE |
| UTI MUTUAL FUND | bulk | Buy | 28 Nov, 2023 | ₹571.00 | 4,45,000 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 29 Nov, 2023 | DHANUKA LABORATORIES LIMITED | Disposal | ₹571.2812869230769230769230769 | 13,00,000 | BSE |
| 25 Jan, 2022 | Dhanuka Laboratories Limited | Revoke | ₹387.0500000312499414063598631 | 80,00,015 | BSE |
| 21 Jan, 2022 | Dhanuka Laboratories Limited | Revoke | ₹415.4000000166666361111671295 | 1,20,00,022 | BSE |
| 03 Jul, 2021 | Dhanuka Laboratories Limited | Pledge | ₹916.6649861141921239811060346 | 1,20,00,022 | BSE |
| 27 Jun, 2021 | M/s Dhanuka Laboratories Limited | Disposal | ₹488.2804880316696213394957189 | 32,80,115 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 19 Feb, 2025 | BSE India | Orchid Pharma''s Alathur API facility successfully completes USFDA Inspection, maintaining its position as India''s only USFDA approved facility for Sterile Cephalosporins. |
| 19 Feb, 2025 | NSE India | Orchid Pharma Limited has informed the Exchange regarding a press release dated February 19, 2025, titled ""Orchid Pharma''s Alathur API facility successfully completes USFDA inspection, maintaining its position as India''s only USFDA approved facility for Sterile Cephalosporins."". |
| 15 Feb, 2025 | BSE India | Transcript of Analyst/ Investor earning call held with public at large on February 12, 2025 for Financial Results of Quarter III of FY 2024-25 ended on December 31, 2024- Orchid Pharma Limited |
| 15 Feb, 2025 | NSE India | Orchid Pharma Limited has informed the Exchange about Transcript |
| 12 Feb, 2025 | BSE India | Audio Recording of the Analysts/Investors Earnings Call for Unaudited Financial results of Quarter III of F.Y. 2024-25 ended on December 31, 2024 - Orchid Pharma Limited |
| 12 Feb, 2025 | NSE India | Orchid Pharma Limited has informed the Exchange about Link of Recording |
| 12 Feb, 2025 | BSE India | Press Release of Orchid Pharma titled as \Orchid Pharma continues on a steady growth path with strengthening market position\. |
| 12 Feb, 2025 | NSE India | Orchid Pharma Limited has informed the Exchange regarding a press release dated February 12, 2025, titled ""Orchid Pharma continues on a steady growth path with strengthening market position"". |
| 12 Feb, 2025 | NSE India | Monitoring Agency Report for the Quarter III of F.Y. 2024-25 ended on December 31, 2024 |
| 12 Feb, 2025 | BSE India | Monitoring Agency Report of the Company for the Quarter-111 of F.Y.2024-25, ended on December 31, 2024. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 07 Feb, 2025 | 12 Feb, 2025 |
| Quarterly Results | -- | 06 Nov, 2024 | 11 Nov, 2024 |
| Quarterly Results | -- | 07 Aug, 2024 | 12 Aug, 2024 |
| Audited Results | -- | 20 May, 2024 | 23 May, 2024 |
| Quarterly Results | -- | 05 Feb, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 31 Oct, 2023 | 04 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 10 Aug, 2023 |
| Audited Results | -- | 04 May, 2023 | 10 May, 2023 |
| Quarterly Results | -- | 06 Feb, 2023 | 09 Feb, 2023 |
| Others | Inter alia, to consider and approve, amongst other things, raising of funds and issuance of securities through Qualified Institutions Placement basis. | 29 Nov, 2022 | 01 Dec, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Orchid Pharma
Orchid Pharma is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 819.37 Cr. and Equity Capital is Rs. 50.72 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Dhanuka Group
Founded
1992
Managing Director
Mr. Manish Dhanuka
NSE Symbol
ORCHPHARMA
Orchid Pharma Management
| Name | Designation |
|---|---|
| Mr. Ram Gopal Agarwal | Chairman & Non-Exe.Director |
| Mr. Manish Dhanuka | Managing Director |
| Mr. Mridul Dhanuka | Whole Time Director |
| Mr. Arjun Dhanuka | Non Executive Director |
| Mrs. Tanu Singla | Independent Director |
| Dr. Dharam Vir | Independent Director |
| Mr. Manoj Kumar Goyal | Independent Director |
| Ms. Shubha Singh | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Orchid Pharma
What is the share price of Orchid Pharma?
The share price of Orchid Pharma on 21 Feb, 2025 is ₹ 920.15.
What is 52W high and 52W low share price of Orchid Pharma?
The highest and lowest 52W share prices of Orchid Pharma are ₹ 1850.000 and ₹ 702.300
What is the market cap of Orchid Pharma?
The market capitalization of Orchid Pharma as of 21 Feb, 2025 is ₹ 4,657.28 Crores
What is the P/E ratio of Orchid Pharma?
The current P/E ratio of Orchid Pharma as of 21 Feb, 2025 is 43.99
What is the PB ratio of Orchid Pharma?
The PB ratio of Orchid Pharma as of 21 Feb, 2025 is 3.98
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)